Physician

Jiantao Ding, MD

According to 2025 Medicare claims, Jiantao Ding, MD (NPI: 1396764551) practices hematology/oncology in the Springfield, MO market, with the plurality of this provider's patient population coming from Greene, MO. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 65807-5230.

Ding's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 539 traditional Medicare patients, billed 97,395 HCPCS/CPT codes, and received $2,167,241 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,971 prescription claims across 321 beneficiaries totaling $7,444,298 in drug costs, led by Imbruvica (Ibrutinib). 2020 DME data shows 38 claims. Open Payments data shows 36 records totaling $935. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,273,983 and ending at $2,167,241. Concurrently, Part D prescription costs have risen steadily, from $2,785,962 to $7,444,298. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,383 to $4,326.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $1,273,983 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,529,978 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,082,445 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,071,813 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,828,721 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,567,597 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,193,125 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,557,527 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,700,261 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,167,241 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015552109,710$1,273,983
2016660123,880$1,529,978
2017623137,032$2,082,445
2018624117,553$2,071,813
201960279,566$1,828,721
2020536109,733$2,567,597
202151883,378$2,193,125
202251186,744$1,557,527
202353183,785$1,700,261
202453997,395$2,167,241

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.7M$7.4M2015 Drug cost: $2,785,962 (USD; Tot_Drug_Cst)2016 Drug cost: $3,095,166 (USD; Tot_Drug_Cst)2017 Drug cost: $3,088,784 (USD; Tot_Drug_Cst)2018 Drug cost: $3,459,628 (USD; Tot_Drug_Cst)2019 Drug cost: $3,255,391 (USD; Tot_Drug_Cst)2020 Drug cost: $3,643,737 (USD; Tot_Drug_Cst)2021 Drug cost: $4,417,634 (USD; Tot_Drug_Cst)2022 Drug cost: $3,778,555 (USD; Tot_Drug_Cst)2023 Drug cost: $5,649,321 (USD; Tot_Drug_Cst)2024 Drug cost: $7,444,298 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152632,054$2,785,962
20162602,082$3,095,166
20172612,088$3,088,784
20182662,021$3,459,628
20192551,799$3,255,391
20202551,721$3,643,737
20212561,728$4,417,634
20222661,652$3,778,555
20232941,810$5,649,321
20243211,971$7,444,298

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.9K$9.9K2015 Medicare payment: $9,864 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,287 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $6,722 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,882 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,036 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R214$9,864
2016N/R95$9,287
2017N/R27$6,722
2018N/R50$3,882
2019N/RN/RN/R
2020N/R38$2,036
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more324768$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more192336$59
80053Blood test, comprehensive group of blood chemicals156424$10
36415Insertion of needle into vein for collection of blood sample280768$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3231,045$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib671,876$1,082,459
JakafiRuxolitinib Phosphate471,410$793,930
RevlimidLenalidomide401,120$762,029
FotivdaTivozanib Hcl22616$666,043
BrukinsaZanubrutinib401,200$554,378

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$935Celgene Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jiantao Ding, MD?

Tedicare shows public-source Medicare data for Jiantao Ding, MD (NPI 1396764551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jiantao Ding, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jiantao Ding, MD?

Jiantao Ding, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Jiantao Ding, MD have Open Payments data?

Jiantao Ding, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.